Routine

Lichen planus (cutaneous, oral & genital)

lichen planus, LP, oral lichen planus, erosive lichen planus, lichenoid, Wickham striae, lichen planopilaris · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

T-cell-mediated inflammatory disorder of skin and mucosa. Classic 'purple, pruritic, polygonal, planar papules' with Wickham striae, flexor wrists/ankles and Koebnerisation. Mucosal (oral/genital) disease may be erosive and painful; scalp disease (lichen planopilaris) scars. Associated with hepatitis C in some populations and with lichenoid drug eruptions.

Red flags

  • Erosive oral or genital lichen planus - chronic, painful, and premalignant (SCC) - needs biopsy and surveillance
  • Scarring scalp disease (lichen planopilaris) - irreversible alopecia, treat early
  • Rapidly extensive/bullous or ulcerative LP
  • New or non-healing ulcer/induration within long-standing mucosal LP - exclude SCC
  • Oesophageal/laryngeal involvement (dysphagia, hoarseness) in mucosal LP

Assessment

Differential diagnosis

  • Lichenoid drug eruption (thiazides, ACE inhibitors, antimalarials, beta-blockers, gold, anti-TNF)
  • Psoriasis / guttate
  • Eczema / lichen simplex
  • Pityriasis rosea
  • Discoid lupus erythematosus (scalp/mucosa)
  • Secondary syphilis
  • Oral: candidiasis, leukoplakia, pemphigus/pemphigoid, SCC
  • Graft-versus-host disease (lichenoid)

Investigations

  • Clinical diagnosis; dermoscopy shows Wickham striae
  • Skin or mucosal biopsy if diagnosis uncertain or to exclude malignancy (erosive oral/genital)
  • Hepatitis C serology where locally indicated / risk factors
  • Medication review for lichenoid drug trigger
  • Patch testing if oral LP adjacent to dental amalgam suspected

Management

  • Confirm diagnosis and review drugs (stop/substitute likely lichenoid culprits)
  • Cutaneous LP: potent/very potent topical corticosteroid + emollient + antihistamine for itch; usually self-limiting over 1-2 years
  • Widespread/resistant cutaneous disease: phototherapy (NB-UVB) or short course oral corticosteroid; acitretin as alternative (specialist)
  • Oral LP: reticular asymptomatic form - reassure, oral hygiene, avoid triggers; erosive/painful - topical corticosteroid (gel/mouthwash/paste) +/- topical calcineurin inhibitor
  • Genital/erosive LP: potent topical corticosteroid; gynae/urology/dermatology input; screen for vulvovaginal-gingival syndrome
  • Lichen planopilaris (scalp): early potent topical/intralesional steroid +/- systemic therapy to prevent scarring alopecia - refer promptly
  • Long-term surveillance of erosive oral/genital LP for squamous cell carcinoma
  • Address pain and quality of life

Drugs & doses

Potent topical corticosteroid e.g. betamethasone valerate 0.1% or clobetasol propionate 0.05% once-twice daily to cutaneous lesions
Emollient + sedating antihistamine (e.g. chlorphenamine) for pruritus
Oral LP: betamethasone or clobetasol in a mucoadhesive base, or soluble betamethasone 0.5 mg dissolved as mouthwash twice daily [verify local]
Topical tacrolimus 0.1% ointment twice daily for erosive oral/genital LP (steroid-sparing) [verify local]
Prednisolone 0.5 mg/kg/day ORAL short tapering course for severe/widespread disease - specialist [verify local dose]
Acitretin 25-30 mg ORAL once daily for recalcitrant cutaneous LP (teratogen) - specialist [verify local dose]
NB-UVB phototherapy for widespread cutaneous disease [verify local]
Intralesional triamcinolone for hypertrophic lesions or lichen planopilaris [verify local dose]

Disposition

Community/GP for limited cutaneous disease. Dermatology referral for widespread, erosive mucosal, genital, scalp (scarring) or refractory disease; MDT (oral medicine/gynaecology) and malignancy surveillance for erosive mucosal LP.

Complications & pitfalls

  • Post-inflammatory hyperpigmentation (prominent in skin of colour)
  • Scarring alopecia (lichen planopilaris), nail dystrophy/pterygium
  • Squamous cell carcinoma in erosive mucosal disease
  • Vulvovaginal/oesophageal stenosis in severe erosive disease
  • Chronic pain and impaired quality of life

Exam pearls

  • Classic '6 Ps': purple, pruritic, polygonal, planar papules and plaques with Wickham striae
  • Always review drugs - lichenoid drug eruptions mimic LP (thiazides, ACEi, antimalarials, anti-TNF)
  • Erosive oral/genital LP is premalignant - biopsy and monitor for SCC long-term
  • Treat scalp (lichen planopilaris) early to prevent permanent scarring alopecia
  • Consider hepatitis C testing where locally prevalent
  • Most cutaneous LP self-resolves within 1-2 years but leaves pigmentation

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.